Search research articles
Contact Us
Filters
Showing results (111-120 of 121) with videos related to
Page
of 13
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
December 15, 2025
Aberrant histone methylation profile in patients with sporadic primary hyperparathyroidism
Poonam Kumari, Sanjay Kumar Bhadada, Ashutosh Kumar Arya, et al.
Frontiers in Endocrinology
|
January 23, 2024
An audit of medullary thyroid carcinoma from a tertiary care hospital in northwest India
Ananda Mohan Chakraborty, Ashutosh Rai, Rimesh Pal, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 2, 2021
GCM2 Silencing in Parathyroid Adenoma Is Associated With Promoter Hypermethylation and Gain of Methylation on Histone 3
Priyanka Singh, Sanjay Kumar Bhadada, Divya Dahiya, et al.
Clinical Endocrinology
|
September 4, 2019
Minimally invasive parathyroid carcinoma-A missing entity between parathyroid adenoma and carcinoma: Scintigraphic and histological features
Priyanka Singh, Shelvin Kumar Vadi, Uma Nahar Saikia, et al.
The Lancet Regional Health. Southeast Asia
|
March 29, 2024
Preliminary results of hypofractionated radiotherapy in breast cancer in Chandigarh, India: single-centre, non-inferiority, open-label, randomised, phase 3 trial
Budhi Singh Yadav, Divya Dahiya, Manish Gupta, et al.
Journal of Clinical and Experimental Hepatology
|
December 6, 2021
Experience With Changing Etiology and Nontransplant Curative Treatment Modalities for Hepatocellular Carcinoma in a Real-Life Setting-A Retrospective Descriptive Analysis
Suneel Tohra, Ajay Duseja, Sunil Taneja, et al.
Journal of Bone and Mineral Metabolism
|
August 15, 2021
Baseline renal dysfunction determines mortality following parathyroidectomy in primary hyperparathyroidism: analysis of Indian PHPT registry
Liza Das, Sanjay Kumar Bhadada, Sapara Mohin Arvindbhai, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 8, 2025
HYPofractionated Adjuvant RadioTherapy in 1 Versus 2 Weeks in High-Risk Patients With Breast Cancer (HYPART): Acute Toxicity Results
Budhi Singh Yadav, Shikha Goyal, Divya Dahiya, et al.
Clinical Nuclear Medicine
|
September 14, 2017
Comparative Effectiveness of Ultrasonography, 99mTc-Sestamibi, and 18F-Fluorocholine PET/CT in Detecting Parathyroid Adenomas in Patients With Primary Hyperparathyroidism
Ntk Thanseer, Sanjay Kumar Bhadada, Ashwani Sood, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
July 20, 2022
Multilevel Annotation of Germline MEN1 Variants of Synonymous, Nonsynonymous, and Uncertain Significance in Indian Patients With Sporadic Primary Hyperparathyroidism
Gurjeet Kaur, Sanjay Kumar Bhadada, Mithun Santra, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 121) with videos related to
Sort By:
Page
of 13
The Journal of Clinical Endocrinology and Metabolism
|
December 15, 2025
Aberrant histone methylation profile in patients with sporadic primary hyperparathyroidism
Poonam Kumari, Sanjay Kumar Bhadada, Ashutosh Kumar Arya, et al.
Frontiers in Endocrinology
|
January 23, 2024
An audit of medullary thyroid carcinoma from a tertiary care hospital in northwest India
Ananda Mohan Chakraborty, Ashutosh Rai, Rimesh Pal, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 2, 2021
GCM2 Silencing in Parathyroid Adenoma Is Associated With Promoter Hypermethylation and Gain of Methylation on Histone 3
Priyanka Singh, Sanjay Kumar Bhadada, Divya Dahiya, et al.
Clinical Endocrinology
|
September 4, 2019
Minimally invasive parathyroid carcinoma-A missing entity between parathyroid adenoma and carcinoma: Scintigraphic and histological features
Priyanka Singh, Shelvin Kumar Vadi, Uma Nahar Saikia, et al.
The Lancet Regional Health. Southeast Asia
|
March 29, 2024
Preliminary results of hypofractionated radiotherapy in breast cancer in Chandigarh, India: single-centre, non-inferiority, open-label, randomised, phase 3 trial
Budhi Singh Yadav, Divya Dahiya, Manish Gupta, et al.
Journal of Clinical and Experimental Hepatology
|
December 6, 2021
Experience With Changing Etiology and Nontransplant Curative Treatment Modalities for Hepatocellular Carcinoma in a Real-Life Setting-A Retrospective Descriptive Analysis
Suneel Tohra, Ajay Duseja, Sunil Taneja, et al.
Journal of Bone and Mineral Metabolism
|
August 15, 2021
Baseline renal dysfunction determines mortality following parathyroidectomy in primary hyperparathyroidism: analysis of Indian PHPT registry
Liza Das, Sanjay Kumar Bhadada, Sapara Mohin Arvindbhai, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 8, 2025
HYPofractionated Adjuvant RadioTherapy in 1 Versus 2 Weeks in High-Risk Patients With Breast Cancer (HYPART): Acute Toxicity Results
Budhi Singh Yadav, Shikha Goyal, Divya Dahiya, et al.
Clinical Nuclear Medicine
|
September 14, 2017
Comparative Effectiveness of Ultrasonography, 99mTc-Sestamibi, and 18F-Fluorocholine PET/CT in Detecting Parathyroid Adenomas in Patients With Primary Hyperparathyroidism
Ntk Thanseer, Sanjay Kumar Bhadada, Ashwani Sood, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
July 20, 2022
Multilevel Annotation of Germline MEN1 Variants of Synonymous, Nonsynonymous, and Uncertain Significance in Indian Patients With Sporadic Primary Hyperparathyroidism
Gurjeet Kaur, Sanjay Kumar Bhadada, Mithun Santra, et al.
Page
of 13